Clofenciclan
Tools
Actions
General
Print/export
Print/export
In other projects
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Jytdog (talk | contribs) at 16:48, 29 May 2016 (Reverted edits by 79.74.11.40 (talk) to last version by DePiep). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 16:48, 29 May 2016 by Jytdog (talk | contribs) (Reverted edits by 79.74.11.40 (talk) to last version by DePiep)
Not to be confused with Clofenamide.
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H28ClNO |
Molar mass | 309.874 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Clofenciclan (Chlorphencyclan; Tonquil, Vesitan) is a dopamine-releasing agent developed by Boehringer & Soehne in the 1950s.[1] It proved unpopular as a treatment because of its pronounced stimulant activity.[2]
References
- ^ U.S. patent 3,254,083
- ^ Poeldinger W. Therapeutic experiences with thiopropazate and with a combination of thiopropazate and chlorphencyclan (Vesitan) in psychiatry. (German). Praxis. 1962 Jan 18;51:73-8. PMID 14487367
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories: